Description
Product Description For Pfizer Geodon Ballpoint Pens #3 New:
This listing is for ONE NEW:
Pfizer Geodon
Medical Logo
#3 Collectible Ballpoint Pens New.
FIRSTLY, WE ARE SELLING THIS AS A PFIZER DRUG REP LOGO!!!
Each pen about 5.5 inches long.
Next, #2 pens are silver color and #1 pen is blue in color.
Also, blue pen has a stylus.
Importantly, pens are new but due to age may not write.
Noteworthy, this product does not contain active drug. No drugs are included in this listing.
Background Info For Pfizer Geodon:
Geodon (ziprasidone) is an antipsychotic medication. Notably, it works by changing the effects of chemicals in the brain.
Importantly, physicians use Geodon to treat schizophrenia and the manic symptoms of bipolar disorder. Doctors use it in adults and children who are at least 10 years old. Further, Geodon comes as an oral (by mouth) treatment as an injection.
Physicians use Geodon injection to quickly treat agitation in schizophrenia patients.
Disclaimers For These Pfizer Geodon Ballpoint Pens:
FIRSTLY, WE ENLARGE PHOTOS TO SHOW DETAILS.
NEXT, COLORS ARE SOMEWHAT DIFFERENT IN PERSON THAN IN PHOTO.
Noteworthy, colors of pens you get may vary from shown. Due to different dye lots.
Significantly, pens are metal but not made of silver.
Importantly, minor imperfections as they can come this way new.
Above all, this listing is for pens only. We are not selling any drug / medication .
WE SELL THIS ITEM AS A MEDICAL MEMORABILIA COLLECTIBLE.
This drug rep logo collectible makes a great gift for yourself or someone you know.
SURELY, DON’T MISS OUT ON THIS HARD TO OBTAIN DOCTORS DRUG REP LOGO ITEM!!!
BUY IT NOW!!!
CERTAINLY, 100% GUARANTEE OF AUTHENTICITY.
OUR SUPPLY IS EXTREMELY LIMITED. ONCE WE SELL OUR CURRENT STOCK, NO OTHERS WILL BE AVAILABLE.
For Other medical logo items click here.
Surely, read this listing carefully. Also, ask questions before buying so we can fully satisfy you.
This listing includes free shipping to USA by USPS First Class Mail. With delivery confirmation.
Reviews
There are no reviews yet.